Diagnóstico no invasivo de amiloidosis cardiaca por transtirretina. Caso clínico

Povar Echeverría, Marina; Auquilla Clavijo, PE; Escobedo Palau, JA; Navarro Beltrán, P; Povar Marco, J.
An. sist. sanit. Navar ; 41(2): 263-267, mayo-ago. 2018. ilus
Artículo en Español | IBECS (España) | ID: ibc-173606

Documentos relacionados

  1. Prognostic role of three-dimensional speckle-tracking echocardiography-derived left ventricular global longitudinal strain in cardiac amyloidosis: Insights from the MAGYAR-Path Study.
  2. Illustrative review of cardiac amyloidosis by multimodality imaging.
  3. Unusually seen pattern of <sup>99m</sup>Tc-DPD soft tissue uptake in a patient with AL amyloidosis. Is it an amyloid type indicator in specific cases?
  4. (Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis.
  5. Impact of left ventricular hemodynamic forces in adult patients with treated aortic coarctation and preserved left ventricular systolic function.
  6. [Case of lifetime diagnosis of isolated primary amyloidosis of the heart].
  7. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
  8. Relationship between the strain measures of left atrial function and heart failure worsening.
  9. Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy.
  10. Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.